Tony Kouzarides

The Gurdon Institute University of Cambridge, Cambridge, England, United Kingdom 
"Tony Kouzarides"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leger A, Amaral PP, Pandolfini L, et al. (2021) RNA modifications detection by comparative Nanopore direct RNA sequencing. Nature Communications. 12: 7198
Santos-Rosa H, Millán-Zambrano G, Han N, et al. (2021) Methylation of histone H3 at lysine 37 by Set1 and Set2 prevents spurious DNA replication. Molecular Cell
Kouzarides T, Pandolfini L, Barbieri I, et al. (2020) Further Evidence Supporting N7-Methylation of Guanosine (mG) in Human MicroRNAs. Molecular Cell. 79: 201-202
Barbieri I, Kouzarides T. (2020) Role of RNA modifications in cancer. Nature Reviews. Cancer
Wein S, Andrews B, Sachsenberg T, et al. (2020) A computational platform for high-throughput analysis of RNA sequences and modifications by mass spectrometry. Nature Communications. 11: 926
Tzelepis K, Rausch O, Kouzarides T. (2019) RNA-modifying enzymes and their function in a chromatin context. Nature Structural & Molecular Biology. 26: 858-862
Samudyata, Amaral PP, Engström PG, et al. (2019) Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. Experimental Cell Research
Pandolfini L, Barbieri I, Bannister AJ, et al. (2019) METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation. Molecular Cell
Wiese M, Bannister AJ, Basu S, et al. (2019) Citrullination of HP1γ chromodomain affects association with chromatin. Epigenetics & Chromatin. 12: 21
Albertella M, Blackaby W, Fosbeary R, et al. (2019) Abstract B126: A small molecule inhibitor of the RNA m6A writer METTL3 inhibits the development of acute myeloid leukemia (AML) in vivo Molecular Cancer Therapeutics. 18
See more...